Furthermore, it will be crucial for stigma-reduction efforts to be wide-reaching and designed for a variety of audiences (e.g., public health campaigns for the general population, specialized training for healthcare professionals, educational materials for patients to combat self-stigma), particularly as GLP-1s continue to grow in popularity
If you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or an allergic reaction, seek emergency medical attention immediately
14, 2023 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (WeightWatchers, WW, or the Company) announced today the launch of WeightWatchers GLP-1 Program to provide tailored behavioral support for individuals on a GLP-1 medication
: Just two capsules, three times a day is all it takes to fast-track your path to reduced body fat and enhanced energy